• Explore /
  • Poster
  • / Correlation of a novel whole blood RT-PCR assay measuring AR-V7 expression with outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (ABI).

Correlation of a novel whole blood RT-PCR assay measuring AR-V7 expression with outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (ABI).

Abstract Poster

Authors

null

Tilman Todenhöfer

Vancouver Prostate Centre, Vancouver, BC, Canada

Tilman Todenhöfer , Arun Azad , Craig Stewart , Jian Gao , Bernhard J. Eigl , Peter C. Black , Anthony M. Joshua , Kim N. Chi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 223)

DOI

10.1200/jco.2016.34.2_suppl.223

Abstract #

223

Poster Bd #

J16

Abstract Disclosures

Similar Posters

First Author: Esmail M. Al-Ezzi

First Author: Louise Emmett

First Author: Russell Kent Pachynski

First Author: Isabel Aragon